BCG
Binah Capital Group, Inc.
There isn't enough reported data to score BCG yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BCG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BCG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCG.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BCG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.3x | $1.10 | — |
| Cheap | 8x | $1.67 | +52% |
| Fair | 15x | $3.25 | +196% |
| Expensive | 76x | $16.04 | +1358% |
Historical ranges are pointers, not guarantees.
BCG's PE is 5.3x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BCG Forward outlook
There aren't enough analyst estimates for BCG to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.21 | +600% |
| Q2 2026 | $0.16 | +$0.28 |
| Q1 2026 | $0.12 | +$0.24 |
| Q4 2025 | $0.09 | +$0.41 |
| Q3 2025 | $0.03 | +$0.33 |
| Q2 2025 | -$0.12 | +$0.09 |
| Q1 2025 | -$0.12 | +$0.05 |
| Q4 2024 | -$0.32 | -900% |
BCG has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.6M | +9.4% |
| Q2 2026 | $46.5M | +12% |
| Q1 2026 | $48.7M | -0.5% |
| Q4 2025 | $50.5M | +13% |
| Q3 2025 | $46.2M | +9.5% |
| Q2 2025 | $41.5M | +2.1% |
| Q1 2025 | $48.9M | +18% |
| Q4 2024 | $44.6M | +13% |
BCG's revenue is growing: $51M last quarter, up 9.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8% | +3.8 points |
| Q2 2026 | 0.9% | +2.3 points |
| Q1 2026 | 5.5% | +2.5 points |
| Q4 2025 | -0.5% | +0.8 points |
| Q3 2025 | 4.2% | +5.7 points |
| Q2 2025 | -1.4% | -0.1 points |
| Q1 2025 | 3% | +6.5 points |
| Q4 2024 | -1.3% | -0.8 points |
BCG has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
BCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1M | +246% |
| Q2 2026 | $1.1M | +1651% |
| Q1 2026 | $527K | -50% |
| Q4 2025 | $3.1M | +79% |
| Q3 2025 | $884K | +$1.2M |
| Q2 2025 | $63K | -94% |
| Q1 2025 | $1M | +$4.2M |
| Q4 2024 | $1.7M | -36% |
BCG has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BCG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +2% | +340K shares |
| 3 years | +11% | +1.8M shares |
| 5 years | +19% | +2.7M shares |
BCG has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | $691 |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $102.9M |
| Q1 2022 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BCG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -3.4x | Net Cash |
| Q1 2025 | -61.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
| Q1 2024 | -0.3x | Net Cash |
BCG has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BCG.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 20.7 | Neutral |
BCG's weekly RSI is 37 (neutral) and its Stochastic is 21 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BCG PE vs Financial Services Sector
| Metric | BCG | Sector median | Relative |
|---|---|---|---|
| PE | 5.3x | 13x | 59% below |
| PE % | 0 | 31 | 31 pts below |
BCG is trading at 5.3x earnings, a 59% discount to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
BCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.07 | 2.8% above |
| 20 week MA | $1.27 | 13% below |
| 50 week MA | $1.76 | 37% below |
| 100 week MA | $1.94 | 43% below |
BCG has stronger trend alignment. BCG is above 1 of 4 weekly averages versus IREN above 1 of 5.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.0 | $2.90 | -78% |
| 2025 | $2.90 | $2.39 | -18% |
| 2026 YTD | $2.39 | $1.10 | -54% |
BCG has finished every year since 2024 lower, and it's down 54% so far in 2026.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN has the edge over BCG on returns for 2026, with the stronger performance.